Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Dapsone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 699Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 8, 2025
    Enforcement Report - Week of January 8, 2025

    08 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-8-2025-53657.pdf

    FDA
    08 Jan 2025
    Share Share
    Enforcement Report - Week of November 13, 2024
    Enforcement Report - Week of November 13, 2024

    13 Nov 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-13-2024-31538.pdf

    FDA
    13 Nov 2024
    Share Share
    Enforcement Report - Week of October 23, 2024
    Enforcement Report - Week of October 23, 2024

    23 Oct 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2024-21885.pdf

    FDA
    23 Oct 2024
    Share Share
    Trupharma`s Generics Dapsone Receives Approval in US
    Trupharma`s Generics Dapsone Receives Approval in US

    26 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213636

    FDA
    26 Aug 2024
    Share Share
    Zydus Pharms' Generic Dapsone Receives Approval in the U.S.
    Zydus Pharms' Generic Dapsone Receives Approval in the U.S.

    08 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214019

    FDA
    08 May 2024
    Share Share
    Padagis' Generic Teriparatide Receives Approval in the U.S.
    Padagis' Generic Teriparatide Receives Approval in the U.S.

    01 Nov 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212657

    FDA
    01 Nov 2023
    Share Share